🔎 Trials Near Me

Home › Idiopathic Thrombocytopenic Purpura › Pennsylvania › Philadelphia

Idiopathic Thrombocytopenic Purpura clinical trials in Philadelphia, PA

3 studies for Idiopathic Thrombocytopenic Purpura are looking for participants at sites in and around Philadelphia (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

RecruitingPhase 3
  • Perelman Center for Advanced Medicine (PCAM) Hospital of The University of Pennsylvania Penn Blood Disorders Program, Philadelphia
  • Lewis Katz School of Medicine at Temple University, Philadelphia
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT06722235

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

RecruitingPhase 3
  • Perelman Center for Advanced Medicine (PCAM) Hospital of The University of Pennsylvania Penn Blood Disorders Program, Philadelphia
  • Lewis Katz School of Medicine at Temple University, Philadelphia
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06948318

Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

RecruitingPhase 1
  • University of Pennsylvania, Perelman Center for Advanced Medicine, Philadelphia
Ages 18 to 85 · All sexes · Updated Jul 22, 2026 · NCT06371417

Idiopathic Thrombocytopenic Purpura trials in other cities

Other studies in Philadelphia

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.